Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06890520 · ClinicalTrials.gov registry record
Neurometabolic Profile of Individuals With Primary Mitochondrial Disease
A clinical trial of Primary Mitochondrial Disease, sponsored by Children's Hospital of Philadelphia.
- Recruiting
- Registry status
- 30
- Enrollment target
- 1
- Study location
NCT06890520 is a study of Primary Mitochondrial Disease that is actively recruiting participants, run by Children's Hospital of Philadelphia. The registered enrollment target is 30 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06890520, a study of Primary Mitochondrial Disease, is actively recruiting participants, sponsored by Children's Hospital of Philadelphia.
- RECRUITING
- Registry status
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
Primary Mitochondrial Disease (PMD) is a genetic neurometabolic disorder, leading to central nervous system degeneration and increased risk of early mortality. There is a strong link between the pathophysiology of mitochondrial disease and biomarkers related to the biochemistry of redox imbalance, involving the levels of glutathione. Investigators will use Magnetic Resonance Imaging and Spectroscopy to non-invasively measure glutathione and other chemicals in the brain to identify redox imbalance in patients with PMD.
Conditions Studied
Study Locations (1)
Pennsylvania
- The Children's Hospital of Philadelphia - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-02-25 |
| Est. Completion | 2029-01-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06890520
The ClinicalTrials.gov registry entry for NCT06890520 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Primary Mitochondrial Disease appearing as the primary indexed condition, and to 0 interventions.
NCT06890520 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06890520 about?
NCT06890520 is a clinical study titled "Neurometabolic Profile of Individuals With Primary Mitochondrial Disease". Primary Mitochondrial Disease (PMD) is a genetic neurometabolic disorder, leading to central nervous system degeneration and increased risk of early mortality. There is a strong link between the pathophysiology of mitochondrial disease and biomarkers related to the biochemistry of redox imbalance, i...
What is the current status of trial NCT06890520?
This trial is currently recruiting. The enrollment target is 30 participants. The study started on 2025-02-25. Estimated completion is 2029-01-01.
What conditions does trial NCT06890520 study?
This clinical trial studies the following conditions: Primary Mitochondrial Disease.
Who is sponsoring clinical trial NCT06890520?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06890520 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Primary Mitochondrial Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.